# Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway

> **NCT06387017** · NA · RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 750 (estimated)

## Conditions studied

- Smoking-related Pathology
- Atheroma
- Non-progressive Cancer > 5 Years
- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** blood sampling
- **DIAGNOSTIC_TEST:** stool collection
- **RADIATION:** low dose CT scan

## Key facts

- **NCT ID:** NCT06387017
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-02
- **Primary completion:** 2028-07
- **Final completion:** 2029-07
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06387017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06387017, "Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06387017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*